SCHEMBL13058476

SCHEMBL13058476

Cc1ccc(-c2nc(C3C(=O)[C@@H]4[C@H](C3=O)[C@H]3CC[C@@H]4O3)c(C)s2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ RAB9A P51151 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ MAPT P10636 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ APP P05067 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ PPARG P37231 1/20 0.33
▸ ALOX5 P09917 3/20 0.32
▸ XBP1 P17861 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13058480 0.90 RAB9A (0.38) SMN1; SMN2LMNAALDH1A1RAB9AKDM4E
SCHEMBL13058493 0.90 KDM4E (0.34) SMN1; SMN2KDM4EGAAMAPTNPC1
SCHEMBL13058507 0.90 MAPT (0.31) KDM4EGAAMAPT
SCHEMBL13058548 0.88 NPC1 (0.40) SMN1; SMN2ALDH1A1RAB9AKDM4EGAA
SCHEMBL13058543 0.88 FBP1 (0.31) —
SCHEMBL13058546 0.86 — —
SCHEMBL13058498 0.85 ALDH1A1 (0.39) SMN1; SMN2LMNAALDH1A1RAB9AKDM4E
SCHEMBL13058527 0.84 RAB9A (0.36) ALDH1A1RAB9AGAAPPARAMAPT
SCHEMBL10237919 0.81 RAB9A (0.38) SMN1; SMN2LMNAALDH1A1RAB9AKDM4E
SCHEMBL13058516 0.80 MAPT (0.32) ALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188294-B1 TRICYCLIC BRIDGED CYCLOPENTANEDIONE DERIVATIVES AS HERBICIDES SYNGENTA LTD (GB) 2015-03-18 — — EP disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
WO-2009030450-A2 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2009-03-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298140-A1 NOVEL HERBICIDES DDT, CYP1B1, CYP1A1 SMN1; SMN2 2924/4885LMNA 4671/4885ALDH1A1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback